SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NNVC - NanoViricides, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: HardToFind who wrote (10997)8/24/2018 12:15:57 PM
From: andy71  Read Replies (1) | Respond to of 12871
 
  1. They didn't have good control of their CMC processes. Now they do
  2. They didn't test with enough different types of flu viruses. not a problem anymore
  3. They were having a very difficult time scaling up to anticipated levels. they have figurered this out ... read 10-q
Once a delay was unavoidable:
  1. They changed the micelle backbone so that it could be absorbed through the stomach. never heard this one
  2. They changed the ligands to be more potent...to mitigate the scale-up issues. that is not why ... they a constantly trying to come up with the mose effective ligand.... period


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News